Can You Take Wegovy Every Two Weeks?

Why is the every-two-weeks question so common?

It comes up more than you might expect. Some people run low on supply and wonder whether halving the frequency is better than stopping entirely. Others look at the cost of a private prescription and think stretching each pen further would ease the monthly outlay. And occasionally the timing just slips (a busy week, a holiday, a pen left at home) and the question becomes: is it safe to carry on at the next scheduled dose or skip a fortnight?

These are all real, practical problems. The issue is that every-two-weeks dosing is not simply a diluted version of the proper schedule. It changes how the medicine behaves in your body in ways that matter clinically, and our page on taking Wegovy every 2 weeks explains those changes and why they matter. Understanding why helps explain what you should actually do when supply or timing becomes complicated.

For a broader overview of how semaglutide works in the context of weight management, the semaglutide overview at nume sets out the mechanism and the licensed use in plain terms.

What does halving the frequency actually do to semaglutide levels in the body?

Semaglutide has a half-life of approximately one week. That figure is not incidental, it is the pharmacological reason the medicine is dosed once weekly. After a weekly injection, semaglutide builds to a steady state over roughly four to five weeks, and that steady state is what produces consistent appetite suppression and the slower gastric emptying that the clinical trials measured.

Extend the gap to two weeks and the steady state collapses. Levels fall substantially in the second week, appetite returns, and many people find the nausea and other gastrointestinal side effects resurface when the next dose eventually arrives, because the body is essentially re-encountering the medicine after a significant gap. If you are wondering whether you can take Wegovy every 2 weeks without these consequences, the short answer is that the pharmacology works against you. The STEP 1 trial, published in the New England Journal of Medicine, demonstrated average weight loss of around 15% over 68 weeks, achieved on the licensed once-weekly schedule. There is no equivalent trial data for an every-two-weeks protocol, because it is not a protocol that exists in the clinical evidence base.

The NHS medicines guidance for semaglutide is equally clear on the dosing interval. You can read the full patient-level detail at the NHS semaglutide medicines page, which also covers what to do if a dose is genuinely missed.

What should you actually do if supply or cost is driving the question?

Cost is a legitimate concern. Private Wegovy prescriptions are not cheap, and the honest answer is that stretching doses is not a safe workaround, but there are proper alternatives worth knowing about.

First, a missed dose. If you miss a single weekly dose and the next scheduled injection is more than two days away, the advice in the patient information leaflet is to take the missed dose as soon as you remember. If it is within two days of the next scheduled dose, skip the missed one. That is very different from deliberately dosing every two weeks, and if you are also asking whether you can take semaglutide every 5 days as a middle ground, that falls outside the licensed schedule for the same reasons. For questions about your specific situation, the nume FAQs cover common scheduling queries, or you can reach the team via the contact page.

Second, if cost is the real issue, it is worth reading through the Wegovy cost breakdown, understanding what is included in a legitimate private prescription (consultation, clinical review, aftercare) helps explain why prices vary and what you are actually paying for. Some providers charge separately for consultations and prescriptions on top of the pen price, which can make the headline figure misleading.

Third, if you genuinely cannot afford to continue, the right route is a supervised pause discussed with your prescriber, not an unsupervised dose-stretching decision made alone. A prescriber can advise on how to re-start safely after a break, including whether slower titration is sensible.

Is there any clinical situation where a longer interval might be considered?

Occasionally, if someone is experiencing particularly difficult side effects on the standard schedule, a prescriber might make a clinical decision to slow the titration pace, spending longer at a lower dose before moving up, for instance. That is a supervised adjustment, documented and reviewed. It is categorically not the same as a patient independently deciding to inject every two weeks at their current dose.

The Wegovy treatment page sets out the licensed titration pathway in full. If you are considering switching from Wegovy injections to the newer oral option, or comparing different approaches to weight management, the weight-loss treatment overview at nume covers the landscape. Any change to your treatment schedule (however minor it seems) is a conversation for your prescriber, not a unilateral adjustment. If you are not currently under clinical care and want to explore what a properly supervised prescription looks like, a free consultation with our prescribers is the place to start.